NucliSENS® EasyQ® HPV v1 test - Testing for oncogenic activity of human papillomaviruses

Journal of Clinical Virology

Volumn 45, Issue SUPPL. 1, 2009, Pages

  Jeantet, Damien ^a   Schwarzmann, Fritz ^a   Tromp, Jessica ^b   Melchers, Willem J G ^c   van der Wurff, Anneke A M ^d   Oosterlaken, Tom ^b   Jacobs, Marcel ^b   Troesch, Alain ^a  

^a BIOMÉRIEUX   (France)

^b Wales Specialist Virology Centre   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d TweeSteden Hospital   (Netherlands)

Author keywords

Cervical carcinoma; E6 E7 mRNA; HPV diagnostics; Human papilloma virus; NASBA; Nucleic acid sequence based amplification; NucliSENS EasyQ

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN E7; ONCOPROTEIN; PRIMER DNA; VIRUS RNA;

ARTICLE; CANCER RISK; CANCER SCREENING; CANDIDA ALBICANS; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC PROCEDURE; DNA VIRUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GARDNERELLA VAGINALIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; UREAPLASMA UREALYTICUM; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; ANALYTICAL EQUIPMENT; BIOSYNTHESIS; COMPARATIVE STUDY; EVALUATION; GENE EXPRESSION PROFILING; GENETICS; METHODOLOGY; PAPILLOMA VIRUS; PATHOGENICITY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

CERVIX UTERI; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 67949124860     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(09)70006-X     Document Type: Article

References (32)

1. Munoz N., Castellsague X., de Gonzalez A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl 3 (2006) S-10-S-31
2. zur Hausen H. Papillomaviruses in the causation of human cancers a brief historical account. Virology 384 (2009) 260-265
3. Wentzensen N., Bergeron C., Cas F., Eschenbach D., Vinokurova S., and von Knebel Doeberitz M. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer 105 (2005) 461-467
4. Wentzensen N., Bergeron C., Cas F., Vinokurova S., and von Knebel Doeberitz M. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Cancer 111 (2007) 58-66
5. Carter J.J., Koutsky L.A., Hughes J.P., Lee S.K., Kuypers J., Kiviat N., et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181 (2000) 1911-1919
6. Frazer I.H. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology 384 (2009) 410-414
7. Wright T.C., Schiffman M., Solomon D., Cox J.T., Garcia F., Goldie S., et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103 (2004) 304-309
8. Meijer C.J., Berkhof J., Castle P.E., Hesselink A.T., Franco E.L., Ronco G., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124 (2009) 516-520
9. Szarewski A., Ambroisine L., Cadman L., Austin J., Ho L., Terry G., et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 17 (2008) 3033-3042
10. van Ham M.A., Bakkers J.M., Harbers G.K., Quint W.G., Massuger L.F., and Melchers W.J. Comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43 (2005) 2662-2667
11. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses (2006) 90
12. Park J.S., Hwang E.S., Park S.N., Ahn H.K., Um S.J., Kim C.J., et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 65 (1997) 121-129
13. Wettstein F.O., and Stevens J.G. Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc Natl Acad Sci USA 79 (1982) 790-794
14. Falcinelli C., Claas E., Kleter B., and Quint W.G. Detection of the human papilloma virus type 16 mRNA-transcripts in cytological abnormal scrapings. J Med Virol 37 (1992) 93-98
15. Hsu E.M., McNicol P.J., Guijon F.B., and Paraskevas M. Quantification of HPV-16 E6 E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 55 (1993) 397-401
16. Sotlar K., Selinka H.C., Menton M., Kandolf R., and Bultmann B. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol 69 (1998) 114-121
17. Munoz N., Bosch F.X., Castellsague X., Diaz M., de S.S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
18. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 (2007) 621-632
19. Bruisten S., van Gemen B., Koppelman M., Rasch M., van Strijp D., Schukkink R., et al. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retroviruses 9 (1993) 259-265
20. el-Galil K.H., el-Sokkary M.A., Kheira S.M., Salazar A.M., Yates M.V., Chen W., et al. Real-time nucleic acid sequence-based amplification assay for detection of hepatitis A virus. Appl Environ Microbiol 71 (2005) 7113-7116
21. Greijer A.E., Adriaanse H.M., Dekkers C.A., and Middeldorp J.M. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA. J Clin Virol 24 (2002) 57-66
22. Lanciotti R.S., and Kerst A.J. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol 39 (2001) 4506-4513
23. Loens K., Ieven M., Pattyn S., Sillekens P., and Goossens H. Sensitivity of detection of rhinoviruses in spiked clinical samples by nucleic acid sequence-based amplification in the presence of an internal control. J Microbiol Methods 66 (2006) 73-78
24. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim van Dillen P.M., and van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28 (1990) 495-503
25. Tyagi S., and Kramer F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14 (1996) 303-308
26. Tyagi S., Bratu D.P., and Kramer F.R. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 16 (1998) 49-53
27. Deiman B., van A.P., and Sillekens P. Characteristics and applications of nucleic acid sequence-based amplification (NASBA). Mol Biotechnol 20 (2002) 163-179
28. Brink A.A., Vervoort M.B., Middeldorp J.M., Meijer C.J., and van den Brule A.J. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J Clin Microbiol 36 (1998) 3164-3169
29. Greijer A.E., Dekkers C.A., and Middeldorp J.M. Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J Virol 74 (2000) 9078-9082
30. Hayes D.P., Brink A.A., Vervoort M.B., Middeldorp J.M., Meijer C.J., and van den Brule A.J. Expression of Epstein Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Mol Pathol 52 (1999) 97-103
31. Molden T., Kraus I., Skomedal H., Nordstrøm T., and Karlsen F. PreTect™ HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 142 (2007) 204-212
32. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 44 (2006) 3122-3129